Clinical Trial Update: Study to Assess Effects of Ublituximab in Pediatric Participants With Relapsing Forms of Multiple Sclerosis [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for a Phase 2/Phase 3 study evaluating ublituximab in pediatric participants with relapsing forms of multiple sclerosis; recruitment has n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing Multiple Sclerosis

Drugs mentioned

• Ublituximab (ublituximab)

Snippet

Sponsor: TG Therapeutics, Inc. | Conditions: Relapsing Multiple Sclerosis | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING